Government moves to have key sickle cell drug made in Tanzania

Dar es Salaam. The government is engaging in discussions with key stakeholders in the healthcare sector to establish a local manufacturer of Hydroxyurea, a medicine used to treat sickle cell.

The discussions according to the chief medical officer, Prof Tumaini Nagu, are focused on establishing a sustainable supply chain and improving access and affordability.